Epigenetic mechanisms as a new approach in cancer treatment: An updated review

被引:149
|
作者
Fardi, Masoumeh [1 ,4 ]
Solali, Saeed [2 ,3 ]
Hagh, Majid Farshdousti [5 ]
机构
[1] Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz, Iran
[2] Tabriz Univ Med Sci, Mol Med Res Ctr, Tabriz, Iran
[3] Tabriz Univ Med Sci, Hematol & Oncol Res Ctr, Tabriz, Iran
[4] Tabriz Univ Med Sci, Div Hematol & Blood Transfus Med, Dept Immunol, Tabriz, Iran
[5] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran
关键词
Cancer; Epigenetic; Mechanisms; Treatment; Methylation; DNA METHYLATION INHIBITORS; PROMOTER METHYLATION; DNMT3A MUTATIONS; SOLID TUMORS; DEMETHYLATION; EXPRESSION; CHROMATIN; GENES; EZH2; HYPERMETHYLATION;
D O I
10.1016/j.gendis.2018.06.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epigenetic, along with genetic mechanisms, is essential for natural evolution and maintenance of specific patterns of gene expression in mammalians. Global epigenetic variation is inherited somatically and unlike genetic variation, it is dynamic and reversible. They are somatically associated with known genetic variations. Recent studies indicate the broad role of epigenetic mechanisms in the initiation and development of cancers, that they are including DNA methylation, histone modifications, nucleosomes changes, non-coding RNAs. The reversible nature of epigenetic changes has led to the emergence of novel epigenetic therapeutic approaches, so that several types of these medications have been approved by the FDA so far. In this review, we discuss the concept of epigenetic changes in diseases, especially cancers, the role of these changes in the onset and progression of cancers and the potential of using this knowledge in designing novel therapeutic strategies. Copyright (C) 2018, Chongqing Medical University. Production and hosting by Elsevier B.V.
引用
收藏
页码:304 / 311
页数:8
相关论文
共 50 条
  • [1] An Updated Review of Epigenetic-Related Mechanisms and their Contribution to Multiple Sclerosis Disease
    Eslahi, Maedeh
    Nematbakhsh, Negin
    Dastmalchi, Narges
    Teimourian, Shahram
    Safaralizadeh, Reza
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2023, 22 (03) : 381 - 393
  • [2] Epigenetic insights in the diagnosis, prognosis, and treatment selection in CRC, an updated review
    Farzaneh Ghadiri Moghaddam
    Safar Farajnia
    Mohammad Karbalaei-Mahdi
    Laleh Monir
    Molecular Biology Reports, 2022, 49 : 10013 - 10022
  • [3] Epigenetic insights in the diagnosis, prognosis, and treatment selection in CRC, an updated review
    Ghadiri Moghaddam, Farzaneh
    Farajnia, Safar
    Karbalaei-Mahdi, Mohammad
    Monir, Laleh
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (10) : 10013 - 10022
  • [4] Sorafenib for the treatment of thyroid cancer: an updated review
    Krajewska, Jolanta
    Handkiewicz-Junak, Daria
    Jarzab, Barbara
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (04) : 573 - 583
  • [5] Mechanisms of cancer cell death induction by paclitaxel: an updated review
    Shuang Zhao
    Yufei Tang
    Ruohan Wang
    Masoud Najafi
    Apoptosis, 2022, 27 : 647 - 667
  • [6] Mechanisms of cancer cell death induction by paclitaxel: an updated review
    Zhao, Shuang
    Tang, Yufei
    Wang, Ruohan
    Najafi, Masoud
    APOPTOSIS, 2022, 27 (9-10) : 647 - 667
  • [7] Epigenetic mechanisms in cancer
    Banerjee, Hirendra Nath
    Verma, Mukesh
    BIOMARKERS IN MEDICINE, 2009, 3 (04) : 397 - 410
  • [8] Review: New horizons in retinoblastoma treatment: an updated review article
    Azimi, Fatemeh
    Mirshahi, Reza
    Naseripour, Masood
    MOLECULAR VISION, 2022, 28 : 130 - 146
  • [9] Delivery systems for vorinostat in cancer treatment: An updated review
    Vu Khanh Hoa Le
    Thi Phuong Dung Pham
    Duy Hieu Truong
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2021, 61
  • [10] Phytochemicals in Skin Cancer Prevention and Treatment: An Updated Review
    Ng, Chau Yee
    Yen, Hsi
    Hsiao, Hui-Yi
    Su, Shih-Chi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (04)